Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma

This publication has 15 references indexed in Scilit:

• Pancreatic Cancer: Current status and future directions in the perioperative treatment of pancreatic cancer
  Annals of Oncology, 1994
• High-dose folinic acid and 5-fluorouracil plus cisplatin on a weekly schedule in the treatment of advanced cancer of the head and neck
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1992
• Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: A feasible and active approach
  Annals of Oncology, 1992
• Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma.
  Journal of Clinical Oncology, 1991
• Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis.
  Journal of Clinical Oncology, 1990
• Continuous Infusion High-Dose Leucovorin with 5-Fluorouracil and Cisplatin for Untreated Stage IV Carcinoma of the Head and Neck
  Annals of Internal Medicine, 1990
• Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.
  Journal of Clinical Oncology, 1989
• Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study.
  Journal of Clinical Oncology, 1988
• Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer.
  Journal of Clinical Oncology, 1988
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958